A carregar...
The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease
Although the rate of cardiovascular disease (CVD)-related mortality has declined over the last decade, it is still the leading cause of mortality in the USA, accounting for over 1.4 million deaths annually. In addition, total direct (primarily hospital admissions) and indirect costs of CVD in the US...
Na minha lista:
| Publicado no: | Cardiovasc Drugs Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5591813/ https://ncbi.nlm.nih.gov/pubmed/28866767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-017-6749-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|